Insights

Strategic Partnerships Qkine has active distribution partnerships with Defined Bioscience, Pluristyx, BioLife Solutions, and REPROCELL, signaling a proven channel strategy and potential for co-selling or expanding footprint in cell culture media, iPSC workflows, and CGT manufacturing.

Cell Therapy Focus The company is developing cell therapy grade recombinant proteins and launched QkPlate vitronectin coated plates, indicating opportunities to cross-sell specialized media, coatings, and GMP/ADCF products to cell therapy developers and contract manufacturers.

Expansion & Innovation Recent product launches (QkPlate line, dried plates) and R-spondin optimizations highlight a pipeline of high-purity growth factors and engineered proteins that could meet growing demand from organoid, regenerative medicine, and cultured meat sectors.

Geographic Reach Cambridge-based manufacturing with global distribution partners suggests potential to scale sales in Europe and the US through existing networks, targeting biotech clusters and academic accounts involved in stem cell and organoid research.

Quality & Compliance ISO 9001:2015 ADCF production with rigorous lot testing offers a quality-driven sales proposition for risk-averse customers in CGT, clinical-grade iPSC work, and regulated research environments seeking reproducible, animal-free growth factors.

Qkine Tech Stack

Qkine uses 8 technology products and services including Cloudflare CDN, Cloudflare DNS, jQuery, and more. Explore Qkine's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Cloudflare DNS
    Domain Name Services
  • jQuery
    Javascript Libraries
  • LinkedIn
    Online Community Software
  • SiteGround
    Platform As A Service
  • reCAPTCHA
    Security
  • YouTube
    Video Players
  • Astra
    Web Platform Extensions

Media & News

Qkine's Email Address Formats

Qkine uses at least 1 format(s):
Qkine Email FormatsExamplePercentage
First.Last@qkine.comJohn.Doe@qkine.com
95%
First@qkine.comJohn@qkine.com
3%
FirstMiddle.Last@qkine.comJohnMichael.Doe@qkine.com
2%

Frequently Asked Questions

What is Qkine's official website and social media links?

Minus sign iconPlus sign icon
Qkine's official website is qkine.com and has social profiles on LinkedInCrunchbase.

What is Qkine's SIC code NAICS code?

Minus sign iconPlus sign icon
Qkine's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Qkine have currently?

Minus sign iconPlus sign icon
As of July 2026, Qkine has approximately 35 employees across 2 continents, including EuropeAsia. Key team members include Chief Executive Officer: R. S.Vp Scientific Operations: A. D.Head Of R&d And Collaborations: L. F.. Explore Qkine's employee directory with LeadIQ.

What industry does Qkine belong to?

Minus sign iconPlus sign icon
Qkine operates in the Biotechnology Research industry.

What technology does Qkine use?

Minus sign iconPlus sign icon
Qkine's tech stack includes Cloudflare CDNCloudflare DNSjQueryLinkedInSiteGroundreCAPTCHAYouTubeAstra.

What is Qkine's email format?

Minus sign iconPlus sign icon
Qkine's email format typically follows the pattern of First.Last@qkine.com. Find more Qkine email formats with LeadIQ.

How much funding has Qkine raised to date?

Minus sign iconPlus sign icon
As of July 2026, Qkine has raised $7.9M in funding. The last funding round occurred on Dec 15, 2022 for $5.2M.

When was Qkine founded?

Minus sign iconPlus sign icon
Qkine was founded in 2016.
Qkine logo

Qkine

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Qkine is a Cambridge-based biotechnology company that produces high-purity, animal-free growth factor proteins to support stem cell, organoid, regenerative medicine, and cellular agriculture research. The firm also develops growth factor technologies aimed at enabling emerging fields such as cultured meat and three-dimensional cell culture. All proteins are manufactured at its Cambridge facility in an animal-derived component-free environment and undergo extensive, lot-specific quality testing to ensure reproducibility, with operations aligned to ISO 9001:2015 standards.

The targeted market comprises researchers in academia and the biotech sector who require defined, reliable growth factors to enable scalable experiments and manufacturing. In 2026, Qkine announced a distribution agreement with Defined Bioscience to extend access to its products outside the United States.

Section iconCompany Overview

Website
qkine.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $7.9M

    Qkine has raised a total of $7.9M of funding over 5 rounds. Their latest funding round was raised on Dec 15, 2022 in the amount of $5.2Mas a series_b.

  • $1M$10M

    Qkine's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $7.9M

    Qkine has raised a total of $7.9M of funding over 5 rounds. Their latest funding round was raised on Dec 15, 2022 in the amount of $5.2Mas a series_b.

  • $1M$10M

    Qkine's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.